A UF team led by Joseph Gullett will conduct the first randomized clinical trial of a new non-invasive device that may improve brain structure and function in adults with Alzheimer’s and mild dementia. The NEUROLITH TPS is a transcranial pulse stimulation device that delivers a low-intensity shock wave to key brain regions.
“Once the data are unblinded ..., we will be able to determine if those who received the TPS demonstrate any thinking and memory changes as well as any lasting changes in their functional abilities in the home, such as ability to cook meals, manage medications and so forth,” says Gullett.
View Related Expert Profiles: Go to Source
